IBRX
ImmunityBio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IBRX Filings
Filing Date
Form Description
Form Type
2025-11-10
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-10 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-05
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-05 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-05
Form 8-K - Current report
Key Events
2025-11-05 · Key Events
Form 8-K - Current report
2025-10-20
Form DEF 14C - Other definitive information statements
2025-10-20 ·
Form DEF 14C - Other definitive information statements
2025-10-08
Form PRE 14C - Other preliminary information statements
2025-10-08 ·
Form PRE 14C - Other preliminary information statements
2025-08-08
Form 8-K - Current report
Key Events
2025-08-08 · Key Events
Form 8-K - Current report
2025-08-05
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-05 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-05
Form 8-K - Current report
Key Events
2025-08-05 · Key Events
Form 8-K - Current report
2025-07-28
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-07-28 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-07-25
Form 8-K - Current report
Key Events
2025-07-25 · Key Events
Form 8-K - Current report
